admin - Relatix Health

April 3, 2026

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

Conditions: Skin and Connective Tissue Diseases; Neglected Tropical Diseases; Leprosy; Buruli Ulcer; Cutaneous Leishmaniasis; Scabies; Mycetoma; Lymphatic Filariasis; Onchocerciasis; Tungiasis; Post Kala-Azar Dermal Leishmaniasis; Yaws; Podoconiosis

Interventions: Device: A mobile app with AI functionality for diagnosing skin-related NTDs

Sponsors: Kenya Medical Research Institute; Universidad Politecnica de Madrid; FACHHOCHSCHULE ZENTRALSCHWEIZ – HOCHSCHULE LUZERN; SHERWOOD HEALTHCARE SENEGAL SARL; King’s College London; TEACUP CONSULTING SL; MTU AUSTRALO ALPHA LAB; OMODI, AGASNA, ODIEMBO ADVOCATES LLP; OEUVRES HOSPITALIERES FRANCAISES DE L’ORDRE DE MALTE; ARMAUER HANSEN RESEARCH INSTITUTE; Leprosy and Tuberculosis Relief Initiative Nigeria; UNIVERSITE CATHOLIQUE DE BUKAVU

Not yet recruiting

April 3, 2026

Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models

Conditions: Breast Neoplasms; Breast Diseases; Ultrasonography

Interventions: Diagnostic Test: Multimodal AI Model Diagnostic Evaluation

Sponsors: Peking Union Medical College Hospital; Chinese Academy of Medical Sciences

Recruiting

April 3, 2026

Prospective Evaluation of Cardiac Point-of-Care Ultrasound (POCUS) Performed by PEM Fellows and Artificial Intelligence Interpretation Compared With a Complete Echocardiography in Children With Preexisting Cardiac Disease

Conditions: Cardiac Anomalies

Interventions: Diagnostic Test: AI Pocus_Cardiac

Sponsors: Nicklaus Children’s Hospital f/k/a Miami Children’s Hospital

Not yet recruiting

April 3, 2026

CABG-AI-Supported Discharge Education

Conditions: Coronary Artery Disease; Postoperative Care; Patient Discharge; Recovery of Function; Anxiety; Pain; Stress, Physiological; Surgical Nursing; Nursing; Discharge Education

Interventions: Behavioral: AI-Supported Individualized Discharge Education; Behavioral: Standard Discharge Education

Sponsors: Hasan Kalyoncu University

Not yet recruiting

April 3, 2026

Evidence of monkeypox virus clade IIb lineage A.2.2 in the Republic of the Congo and co-circulation of clade Ia, Ib and clade IIb

Nature Medicine, Published online: 03 April 2026; doi:10.1038/s41591-026-04256-2

Whole-genome phylogenetic analyses have identified a case of monkeypox virus clade IIb lineage in the Republic of the Congo and co-circulation of three clade lineages, emphasizing the importance of improved surveillance given the risk of possible recombination events in the future.

April 3, 2026

CARED : A Novel Rapid Treatment Paradigm for Depression

Conditions: Major Depressive Disorder

Interventions: Device: Intermittent Theta Burst Stimulation (iTBS); Device: Transcranial Alternating Current Stimulation (tACS); Behavioral: Psychotherapy; Device: Sham (Placebo) Transcranial Alternating Current Stimulation (tACS)

Sponsors: University of North Carolina, Chapel Hill; Foundation of Hope for the Research and Treatment of Mental Illness

Not yet recruiting

April 3, 2026

Efficacy of Spectrally Optimized Light on Cognitive Impairment in Major Depressive Disorder and Its Neuroimaging Mechanisms

Conditions: Major Depressive Disorder (MDD); Neuroimaging; Bright Light Treatment; Cognitive Impairment

Interventions: Device: bright light; Device: dim red light(placebo)

Sponsors: Peking University Sixth Hospital

Not yet recruiting

April 3, 2026

The exposome of brain aging across 34 countries

Nature Medicine, Published online: 03 April 2026; doi:10.1038/s41591-026-04302-z

Exposome analyses across 34 countries showed that social exposures were associated with faster functional brain aging and physical exposures with faster structural brain aging.

April 3, 2026

Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion

Conditions: Concussion; Depression

Interventions: Device: ONE-D TMS protocol and d-cycloserine (125 mg)

Sponsors: University of Florida

Not yet recruiting

April 3, 2026

Target product profiles for treatments to delay or prevent symptomatic Alzheimer’s disease

Nature Medicine, Published online: 03 April 2026; doi:10.1038/s41591-026-04305-w

To accelerate therapeutic development and equip stakeholders with clear benchmarks, the authors outline target product profiles for therapies designed to delay or prevent the onset of clinical symptoms of Alzheimer’s disease.